XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.3
GOODWILL AND INTANGIBLE ASSETS
 12 Months Ended
Sep. 27, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
    The following table reflects goodwill by reportable segment:
(In millions)
Medical
Industrial
Total
Balance at September 29, 2023$171.5 $117.0 $288.5 
Foreign currency translation adjustments
1.5 1.0 2.5 
Balance at September 27, 2024$173.0 $118.0 $291.0 
    The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in intangible assets, net in the Consolidated Balance Sheets:
September 27, 2024September 29, 2023
(In millions)
Gross Carrying Amount
Accumulated Amortization
Net Carrying AmountGross Carrying Amount
Accumulated Amortization
Net Carrying Amount
Acquired existing technology
$73.8 $(63.5)$10.3 $72.3 $(57.8)$14.5 
Patents, licenses and other
12.6 (12.6)— 12.5 (12.2)0.3 
Customer contracts and supplier relationship
52.8 (47.0)5.8 50.3 (42.7)7.6 
Total intangible assets
$139.2 $(123.1)$16.1 $135.1 $(112.7)$22.4 
    Amortization expense for intangible assets was $9.9 million, $13.7 million and $14.6 million in fiscal years 2024, 2023 and 2022, respectively.
    As of September 27, 2024, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
Fiscal Years:
2025$3.8 
20263.7 
20273.4 
20283.3 
20291.6 
Thereafter0.3 
Total$16.1